chrisvoncsefalvay/vaers-outcomes huggingface dataset:
headache; nausea; pain on the injection site; develop little bumps a size of a small pea on the left side of the neck painful and tender/ painful and tender bumps in collar bone cavity and left elbow; a bit feverish; felt numbness on her left leg and feet; she did get itchy and all that like something was crawling on her; did get itchy and all that like something was crawling on her; This is a spontaneous report from a contactable consumer (patient). A 37-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 23May2021 (Batch/Lot number was not reported) as single dose, dose 1 via an unspecified route of administration, administered in Arm Left on 02May2021 (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient received both doses of the Pfizer COVID 19 Vaccine - 1st dose was given on 02May2021 and 2nd dose was on 23May2021. She developed headache, nausea, and pain on the injection site. After a few days she started to develop little bumps a size of a small pea on the left side of the neck painful and tender. She also has painful and tender bumps in collar bone cavity and left elbow. She felt numbness on her left leg and feet. It was reported that she has been feeling, aside from all the nausea, headache, a bit feverish, she did get itchy and all that like something was crawling on her and she took anti-allergy for that. Caller relays she got the vaccine in her left arm and right on her left side of her neck she has a really tender to touch and it feels like a little tiny bump or clot type thing. States that also exactly on the left side almost at the collar bone cavity she can literally feel them like little smaller than a pea size about that size and they were quite tender just to touch and it's painful. Caller states she also felt numbing in her left leg and she never felt this before and it was right after the vaccine. No information on the PI about numbness of leg and feet after taking the vaccine. She tried to contact her doctor, no answer yet. She was asking if these are normal side effects and how to manage it. Caller states she got the information sheet but this is not listed and she was concerned and wanted to know if it relates and it seems to be. Outcome of the events was unknown.  Information about lot/batch number has been requested.
Redness, swelling at inject site. Induration. Systemic - fever / chills - onset 6-12 deg after injection.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 05-AUG-2015, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23, 0.5 ml, (lot # K009105, expiration date 21-JAN-2016) (route and dose were not reported). No adverse effects were reported. This specified lot number vaccine was exposed to temperature excursion twice. The total cumulative excursion time (hour), the lowest recorded temperature (Fahrenheit degree) and the type of excursion (R/F) for the first excursion was 24, 34, and R. The total cumulative excursion time (hour), the highest recorded temperature (Fahrenheit degree) and the type of excursion (R/F) for the second excursion was 176, 48 and R. The storage criteria was refrigerator (R). This is one of several reports received from the same source. Additional information has been requested.
LARGE (5 1/2 x 5 1/2 in.) LOCAL REACTION AT INJECTION SITE.  REDDNESS,WARM, RED,AND EDEMA.  5/ 18/ 2003 11:00.
pt recv vax 3JUN98 & shortly p/vax pt exp a localized, light maculopapular rash (80mm by 120mm) around the inj site;
Hives from head to thighs, onset approx. 3 hours, post vax. Given steroid shot at doctor's office about 7 hours, post vax. Hives improved within 1 hours of steroid shot. Monitored closely for the next 48 hours for any other reaction.
Patient began to complain about bilateral itching to arms and hands and was given Benadryl 50 mg PO and observed for 30 minutes. She was instructed on discharge to call 911 if she began to feel throat or mouth swelling or shortness of breath.
Generalized redness on face, no itching, wheezing, SOB -Benadryl 50 mg PO x1    *symptoms gradually improving after medication
Pain after injection in underarm; Bruising; This case was reported by a physician via call center representative and described the occurrence of axillary pain in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced axillary pain and contusion. On an unknown date, the outcome of the axillary pain and contusion were unknown.   It was unknown if the reporter considered the axillary pain and contusion to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was selected as per the vaccine indication. The reporter sated that, the patient had bruising and pain after injection in underarm.
Headache with profuse vomiting. 1 episode every half hour until controlled with 4mg Zofran. All sx lasted 30 hours.
Hives across belly and some on the back, they lasted all day gave dose of benadryl with no improvement. Next day hives from previous day had gone down but new hives showed up upon waking.
Patient received influenza and pneumococcal vaccine on 9/9/14. Yesterday, 9/10/14, patient had a fever of 102 and then passed out this morning after having a BM. Patient's wife called 911. Pt went to ER and diagnosed with pneumonia.
SPOTS ON BACK HIPS BUTTOCKS AND SLIGHTLY DOWN THE BACK OF THIGHS; SEVERAL RED BLOTCHES SCATTER ON BACK; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. Non-company suspect drugs included: influenza vaccine ( form of admin, route of admin, and batch number were not reported) dose and frequency were not reported from OCT-2021 for an unspecified indication. No concomitant medications were reported. On an unspecified date, the patient experienced spots on back hips buttocks and slightly down the back of thighs, and several red blotches scatter on back. Treatment medications (dates unspecified) included: cortisone, and montelukast sodium. The action taken with covid-19 vaccine ad26.cov2.s was not applicable; and action taken with influenza vaccine was not reported. The patient had not recovered from several red blotches scatter on back, and the outcome of spots on back hips buttocks and slightly down the back of thighs was not reported. This report was non-serious.
This spontaneous report as received from a Licensed Practical Nurse refers to a 4 month old patient of unknown gender. No pertinent medical history, concurrent conditions, drug reactions, allergies or concomitant therapies were provided. On 27-JUN-2018, the patient was vaccinated with an improperly stored dose of PEDVAXHIB lot # R001085, expiration date on 30-SEP-2020, for prophylaxis (dosage schedule, route and anatomical location were not reported). There was no adverse effect reported. Administered dose of vaccine experienced the temperature excursion of 0 to 1 (1.4) degrees Celsius for 3 hours. Digital Data logger was involved. There were no previous excursions reported. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1807USA004691: US-009507513-1807USA012291: US-009507513-1807USA012292: US-009507513-1807USA012304: US-009507513-1807USA012294: US-009507513-1807USA012295: US-009507513-1807USA012296: US-009507513-1807USA012297: US-009507513-1807USA012298: US-009507513-1807USA012299: US-009507513-1807USA012300: US-009507513-1807USA012301: US-009507513-1807USA012302: US-009507513-1807USA012303: US-009507513-1807USA012289: US-009507513-1807USA012288: US-009507513-1807USA012287: US-009507513-1807USA012286: US-009507513-1807USA012293.
Within minutes after the first dose my ears started ringing/It never stopped/The ringing is constant since the first dose/Thirty days later the ears were still ringing; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Within minutes after the first dose my ears started ringing/It never stopped/The ringing is constant since the first dose/Thirty days later the ears were still ringing) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033B21A and 025C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Jul-2021, the patient experienced TINNITUS (Within minutes after the first dose my ears started ringing/It never stopped/The ringing is constant since the first dose/Thirty days later the ears were still ringing). At the time of the report, TINNITUS (Within minutes after the first dose my ears started ringing/It never stopped/The ringing is constant since the first dose/Thirty days later the ears were still ringing) had not resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Patient takes concomitant medication but not willing to disclose. No treatment medications were provided.
This spontaneous report as received from a Nurse Practitioner refers to an 8 weeks old patient. The patient was vaccinated orally with first dose of ROTATEQ on an unspecified date. No other co-suspects were reported. No concomitant medications were reported. On an unknown date the patient experienced rotavirus. The patient went to the E/R. At the time of the report, the patient had recovered. Additional information has been requested.
Bell's palsey following sinusitis that was on/off for a few weeks, previous week had a stressful event. Full muscle paralysis of right side of face, no loss of sensation. Recover better than 50% of muscular motion after four weeks.
Pain and swelling next day, high fever 1 week later, hair loss 4-5 months later.
ARM IS INFLAMED AND ITCHY. IT IS VERY RED AND HOT TO THE TOUCH.
Within one minute, my son passed out.  was out for 30 seconds.  I had to catch him from falling off of the exam table.
I started having some pain in my wrist and in my thumb. It happened one morning. It started to get better then got worse again. I went to the urgent care center on 09/28/2022. The diagnosed me Tenosynovitis. The put me in an immobilizing splint for my thumb and wrist for 2 weeks.  I was advised to not use my thumb and wrist. They prescribed Meloxicam for pain. I was also advised to take Prilosec to protect my stomach. It is still throbbing but the less I move the better I feel.
This spontaneous report as received from a nurse refers to a patient of unknown age. The patient was vaccinated with ZOSTAVAX (lot # was reported as H011431, expiration date was 12-SEP-2013, dose and route were unknown) on 01-NOV-2012, that had been exposed to temperatures of 56 degrees F for 19 hours. No other co-suspects were reported. No concomitant medications were reported. No adverse effect reported. At the report time the outcome of event was unknown. It was unknown if the patient sought medical attention. Additional information has been requested.
Sporadic bouts of dizziness beginning day after vaccine. Usually goes away or becomes not as evident after sitting and resting for a few.
c/o headache, pressure in her head, c/o pain in arm at injection. Physician assessed patient and d/c back to work in stable condition.
Fine prior to shot. Day after shot, felt bad. Progressed to high fever (102 degrees), loss of appetite, extreme tiredness/weakness, sore throat. Fever, loss of appetite, extreme tiredness/weakness lasted approximately 7 weeks. Lost 10 pounds and struggled to get out of bed. Given Z-PAK and generic LEVAQUIN, but these antibiotics had no effect on fever, tiredness or weakness. TYLENOL and ibuprofen would give limited relief from fever. Blood work erratic, ultimately diagnosed w/anemia and UTI.
Severe back pain, unbearable to sit or lean back, painful to the touch. Took Advil 24 hours after having the vaccine.
As I was leaving the store and lifted my left arm (the arm I had the shot in) up to open the door I experienced a very sharp pain in my arm and was not able to lift my arm up completely and had to use my other arm to open the door. The pain persisted the entire day-very sore, felt weak, and unable to lift or move arm without pain. This continued for 6 months with moderate to severe pain, stiffness, and weakness particularly upon moving the arm. I also could not sleep on my side of that arm and if I did so without realizing it while asleep, it would awaken me with pain. The pain, stiffness, and weakness began to lift after 6 months and then to a mild pain after 8 months. At about 9-12 months the symptoms resolved completely.
Allergies: PNEUMOVAX 23 INJ 25MCG/0.5ML SDV; This spontaneous report has been received from an elderly female patient of unknown age, regarding their self, via Pfizer Inc.   The patient's pertinent medical history and concurrent conditions included cancer or neoplasm, malignant neoplasm of breast, malignant neoplasm of bone, diabetes mellitus, hypothyroidism, hypertension and hyperlipidemia. Their concomitant medications included insulin lispro (HUMALOG) 100 units (U) per milliliter (ml) kwik pen injection, insulin glargine (LANTUS SOLOSTAR) pen injection 3 ml, metoprolol tartrate 10 milligrams (mg) tablet, simvastatin 10 mg tablet, calcium carbonate (+) colecalciferol (CALCIUM 500+D3) tablet, cyanocobalamin (VITAMIN B-12) 250 microgram (mcg) tablet.  Their drugs reactions or allergies were not provided.  On an unknown date, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, 25mcg per 0.5ml (dose, vaccination scheme, frequency, route of administration, lot number, expiration date and anatomical injection site was not provided) for prophylaxis and experienced an allergy (drug hypersensitivity). The outcome of the event drug hypersensitivity was not provided.   The causality assessment between the event drug hypersensitivity with the suspect pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was related.
Sore arm at injection site; This is a spontaneous report from a contactable consumer (patient). A 31-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration (left arm) on 26Jan2021 09:00 (at the age of 31years) at single dose for Covid-19 immunization. The patient's medical history included Covid-19 (prior to vaccination the patient diagnosed with COVID-19). Concomitant medications included cetirizine hydrochloride (ZYRTEC) and fluticasone propionate (FLONASE); both from an unspecified date for an unspecified indication. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 27Jan2021 07:00, the patient experienced sore arm at injection site. There was no treatment received for the adverse event. The patient has not been tested for COVID-19 since the vaccination. The outcome of event was recovering. This case is non-serious.  Information on the lot/batch number has been requested.
This is a spontaneous report from a contactable nurse. A 24 month old male child (Birth weight: 08 Lbs. and 10 ounces) started taking PREVNAR 13, 0.5 ml, single, intramuscular injection on his right thigh on an unknown date. Relevant medical history includes sinus infection from which he had recovered on an unknown date. Number of brothers and sisters/siblings was 2. Relevant concomitant medications included AUGMENTIN and NASONEX. Vaccines given on the same day included polio vaccine (Sanofi Pasteur, Bath/Lot H1330), dose2, intramuscularly in the right thigh. Vaccines taken within the last four weeks were none. In Apr2012 while on PREVNAR 13 unknown dose unknown frequency he had arthritis associated symptoms which was explained as knee pain, swelling of joint, knee swelling and redness. Relevant lab data was none. At the time of the report it was unknown if he was taking PREVNAR 13. At the time of the report he had not recovered from the above mentioned events.
I had fatigue and body aches for the first 2 days. I started to feel better then on the 3rd night I woke up with a migraine and nausea. The same thing happened after my 6th dose but vomiting instead of nausea.
Joint pain and nausea for 12 hours, severe injection site pain for 48 hours
This spontaneous report as received from a nurse. She states that doses of MMR II and ROTATEQ that were exposed to 50F for 48 hours were administered to patients. The patients were vaccinated with MMR II. Other suspect therapies included ROTATEQ. No concomitant medications were reported. On an unknown date the patient experienced doses of MMR II and ROTATEQ that were exposed to 50F for 48 hours were administered to patients. No treatment information was reported. Doses of MMR II and ROTATEQ that were exposed to 50F for 48 hours were administered to patients is not related to MMR II and ROTATEQ. At the time of the call, she does not know who received the doses of improperly stored vaccine, but she would like to know if they should be revaccinated. She will call to provide details when she is able to retrieve the information. SR # provided. It is not known at this time if there have been any adverse effects. Rotavirus vaccine Lot # 0210AE, Date Given 10/31/2012. Additional information has been requested.
Initial and follow up information has been received from a registered nurse and a completed questionnaire concerning a 26 year old caucasian female with a history of 1 pregnancy and 1 live birth, who on 09/15/2003 was vaccinated with a dose of measles virus vaccine live, mumps virus vaccine live, rubella virus vaccine live.  There was no concomitant medication.  On 10/23/2003 the patient underwent an ultrasound, which revealed that the patient was 8 weeks 3 days gestation.  The ultrasound was reported as appropriate fetal growth and the fetal heartbeat was within normal limits.  In follow-up, the questionnaire reported that the patient was placed on pre-natal vitamin therapy.  During pregnancy the patient developed a urinary tract infection, which was treated with amoxicillin.  The outcome of the urinary tract infection was not reported.  The patient underwent unspecified diagnostic tests during pregnancy, which revealed normal results.  On 05/29/2004, at 40 weeks from patient's last menstrual period, the patient delivered a normal live, female infant.  The infant weighed 7 lbs and 3 oz.  No further information is expected.
Swelling of leg and increased fussiness- swelling and fussiness resolved, but baby is not nearly as active as she was prior, not smiling and laughing like she was, more passive
WEDNESDAY -NOVEMBER 3RD-HEADACHE,SORE THROAT,BODY ACHES,MUSCLE SPASM,CHILLS, FEVER,FEEL NAUSEOUS                 THURSDAY- NOVEMBER 4TH TO NOVEMBER 6TH-HEART PALPITATIONS, ,SWEATING  IN UNDERARMS, FEET AND HANDS                                                                            SUNDAY - NOVEMBER- 7TH- NUMBNESSIN LEFT THUMB DIZZINESS HIGH BLOOD PRESSURE AND HEART RATE
103.7 fever over 3 day span--kept that temp consistently for 3 days despite motrin (and some Tylenol alternating). On day 4, fever decreased with motrin/tylenol--shooting up promptly when dose wore off. 3 days following shot experienced exhaustion, fatigue, decreased breath/lung capacity, severe pain of body/muscles/bones, severe chills. On day 5, fever stayed down normally. Symptoms which persist one month later (today is 4/29/21) include decreased lung/breathing capacity, wheezing, fatigue, exhaustion, sensations (tingly face/limbs--arms esp) with feelings of swelling face/body, anxiety. Repeated use of rescue inhaler only offers brief relief--requiring continued use throughout day/night. Pulse ox registered 90 on 4/29/21 per school nurse/school clinic.
Left deltoid with erythema, swelling surrounding injection site.  Patient was given MEDROL (pak) 4 mg take as directed ATARAX 25 mg 1 four times a day as needed.
Vaccine given 4/10/2006, 2 days later redness, not to touch, 4x2cm induration, dizziness, fatigue, nausea, low grade fever.
Insomnia. The night of my 2nd vaccination I woke up at 430am and was wide awake. I could not fall back asleep until about 6am. The following day I was very jittery and ancy. Since then I have been restless at night and most nights wake up at 430am and not able to go back to sleep for a cpl of hours.
Severe pain affected arm without rash or swelling, flu-like symptoms (body aches, feverishness), inability to sleep due to discomfort. After approximately 12 hours, began to improve.
Not feeling well; My lymph node is swollen underneath my armpit; I am in pain; I received my third on Tuesday; I received my third on Tuesday; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 17Aug2021 as dose 3, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously received BNT162B2 for Covid-19 immunization (both dose number 1 and 2). The patient reported I received my third on Tuesday and I am not feeling well, and my lymph node is swollen underneath my armpit, and I was in pain all on an unspecified date in 2021. The outcome of the events was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
crying w/leg movement; no redness; no mass; no tx; dx normal react to DTP by MD:
Numbness on the left side of neck and jaw (side of injection site). Lasted for about 2 weeks.
Bells Palsy - Valtrex 1g PO TID x7d, Prednisone 60 mg daily x7d
Pt. presented to clinic w/ documentation showing she rec'd Moderna vaccine on 3/10/2021 d/t pts. age, 2nd vaccine recommended was Pfizer, Pfizer administered per pts. guardian consent.
Shingles; This is a spontaneous report from a contactable consumer (patient). A 28-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: ER8730), dose 2 via an unspecified route of administration, administered in right arm on 01Apr2021 16:00 (at the age of 28-year-old) as single dose for covid-19 immunisation at doctors office/urgent care. The patient medical history included ongoing selective IgA deficient and ongoing IBS (irritable bowel syndrome). The was not patient diagnosed with COVID-19, prior to vaccination. The patient concomitant medication included amoxicillin, received within 2 weeks of vaccination. The patient previously took codeine phosphate (CODINEX) and experienced allergies. Historical vaccine included dose 1 BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EN6204) via an unspecified route of administration, administered in right arm on 11Mar2021 at 16:00 as single dose for covid-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced shingles on 24May2021. Adverse event result in doctor or other healthcare professional office/clinic visit. Treatment received for the adverse event with antiviral medications. The had not patient been tested for COVID-19 since the vaccination. The outcome of the event was recovering.  Follow-up attempts are completed. No further information is expected.